Skip to content

S 446 · New Jersey · 222 · Billy

Skip to content

Home
/
Bills
/
New Jersey
/
222
/
S 446

New Jersey · 222 session · senate

S 446Requires health benefits plans to cover abuse-deterrent opioid analgesic drug products.

Status: In committee
Latest action: 2026-01-13 — Introduced in the Senate, Referred to Senate Commerce Committee
Primary sponsor: Stack, Brian P. (Democratic)

Commerce

Track this bill

Sponsors

Stack, Brian P. (Democratic) · primaryprimary

Versions

IntroducedJan 13, 2026

Legislative history

Public legislative record via Billy. Sign in to track, annotate, and export work product.

About public bill pages Compare Billy New Jersey bill RSS

Jan 13, 2026

Introduced in the Senate, Referred to Senate Commerce Committee

Official sources

Version 0PDF HTML

About this page

Is this the official New Jersey bill page?: No — this is Billy’s public legislative record for S 446. Official source links are listed above when publishers provide them.
Can I track updates?: Yes. Sign in to track S 446, get alerts, annotate diffs, and export Word work product.